稳心颗粒联合美托洛尔治疗心律失常患者的临床分析

目的观察稳心颗粒联合美托洛尔治疗心律失常患者的临床疗效。方法2010年1月～2011年1月，112例心律失常患者随机分为两组，观察组56例采用稳心颗粒联合美托洛尔进行治疗，对照组56例采用美托洛尔治疗，对比观察两组的临床及心电图疗效。结果观察组的心律失常治疗的总有效率明显高于对照组，两组比较差异有统计学意义（P〈0．05）。两组治疗后室早、短阵室速和ST段降低持续时间明显下降，与治疗前比较差异有统计学意义（P〈0．05）。并且观察组治疗后心电图改善情况明显优于同期对照组，两组比较差异有统计学意义（P〈0．05）。结论稳心颗粒联合美托洛尔对心律失常患者进行治疗，能够明显提高临床和心电图疗效，值得临床推广应用。

The Clinical Analysis of Metacenter Particle Combined Metoprolol in Treatment Arrhythmia

Objective To observe the effect of metacenter particle combined metoprolol in treatment arrhythmia. Methods All 112 cases arrhythmia patients were randomly classified into two groups, which observation group with 56 cases was treated with metacenter particle combined with metoprolol, and control group with 56 cases was treated with metoprolol. The clinical effect and electrocardiogram effect between the two groups were compared. Results The total effective rate in observation group was significantly higher than that in control group （P 〈 0.05 ）. Compared with pre-treatment, ventricular premature beats, nonsustained ventricular tachyeardia and ST segment depression duration in both two groups were significantly decreased （P 〈 0.05 ）. Moreover, the improvement of electrocardiogram effect in observation group was significantly better than that in control group （ P 〈 0.05 ）. Conclusion Metacenter particle combined metoprolol in treatment arrhythmia can improve clinical effect and electrocardiogram effect, which can be applied in clinic.